Russian prostate cancer study tracks real-world treatments and genetic clues

NCT ID NCT07052578

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study observes 400 men in Russia with aggressive, high-volume metastatic hormone-sensitive prostate cancer. Researchers will track which treatments doctors use (like hormone therapy, chemotherapy, or radiation) and test blood samples for genetic mutations. The goal is to understand current care patterns and how genetic testing might guide future decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Research Site
RECRUITING

Arkhangelsk, Russia
Research Site
RECRUITING

Barnaul, Russia
Research Site
RECRUITING

Chelyabinsk, Russia
Research Site
RECRUITING

Irkutsk, Russia
Research Site
NOT_YET_RECRUITING

Kazan', Russia
Research Site
RECRUITING

Krasnodar, Russia
Research Site
RECRUITING

Krasnoyarsk, Russia
Research Site
RECRUITING

Moscow, Russia
Research Site
NOT_YET_RECRUITING

Moscow, Russia
Research Site
WITHDRAWN

Moscow, Russia
Research Site
RECRUITING

Nal'chik, Russia
Research Site
RECRUITING

Nizhny Novgorod, Russia
Research Site
RECRUITING

Obninsk, Russia
Research Site
WITHDRAWN

Omsk, Russia
Research Site
NOT_YET_RECRUITING

Pskov, Russia
Research Site
NOT_YET_RECRUITING

Saint Petersburg, Russia
Research Site
WITHDRAWN

Saint Petersburg, Russia
Research Site
NOT_YET_RECRUITING

Saransk, Russia
Research Site
WITHDRAWN

Sochi, Russia
Research Site
NOT_YET_RECRUITING

Syktyvkar, Russia
Research Site
WITHDRAWN

Tomsk, Russia
Research Site
RECRUITING

Tomsk, Russia
Research Site
WITHDRAWN

Tver', Russia
Research Site
RECRUITING

Tyumen, Russia
Research Site
RECRUITING

Ufa, Russia
Research Site
RECRUITING

Yekaterinburg, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.